GSH (-glutamyl-cysteinyl-glycine) is synthesized de novo in two sequential enzymatic ATP-dependent reactions
GLP-1 receptors are present in brain regions involved in mood regulation, such as the hippocampus and amygdala
Side Effect Profiles Both medications share similar side effect profiles since they work on overlapping pathways
It is not approved for human use, consumption, or therapeutic application
Journal of Aging Science , 4(1), 166
The agency proposed excluding semaglutide, tirzepatide, and liraglutide the active ingredients in popular GLP-1 medications like Wegovy, Ozempic, Zepbound, and Mounjaro from the list of drugs that large-scale compounding pharmacies can produce